Related Experiment Video
Updated: Jun 28, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Recent landmark trials in cardiology.
1Escorts Heart Institute and Research Centre, New Delhi.
Recent clinical trials focus on acute myocardial infarction/acute coronary syndrome, implantable cardioverter-defibrillators, heart failure, and coronary revascularization strategies. These studies offer insights into managing critical cardiovascular conditions.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Clinical Trials
Background:
- Recent advancements in cardiovascular medicine necessitate updated clinical evidence.
- Understanding the efficacy of various treatments for acute and chronic heart conditions is crucial.
Purpose of the Study:
- To review and present findings from recent clinical trials.
- To cover key areas including acute coronary syndromes, device therapy, heart failure management, and revascularization techniques.
Main Methods:
- Systematic review of recent clinical trial data.
- Focus on trials related to acute myocardial infarction/acute coronary syndrome.
- Inclusion of trials on implantable cardioverter-defibrillators, heart failure, and revascularization procedures.
Main Results:
- Summaries of key outcomes from selected clinical trials.
- Comparative analysis of percutaneous coronary intervention versus coronary artery bypass graft for multivessel coronary artery disease.
- Evidence-based insights into current cardiovascular treatment paradigms.
Conclusions:
- Recent trials provide valuable data for optimizing patient care in cardiology.
- Findings support evidence-based decision-making for acute myocardial infarction, heart failure, and coronary artery disease management.
- The presented trials highlight progress in implantable device therapy and revascularization techniques.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy V: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
